Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
H.C. Wainwright initiated coverage of Agios Pharmaceuticals (AGIO) with a Buy rating and $58 price target The firm views the company’s lead ...
What is HC Wainwright’s Estimate for Prothena Q4 Earnings?
Investment analysts at HC Wainwright issued their Q4 2025 EPS estimates for Prothena in a research note issued to investors on Friday, February 21st. HC Wainwright analyst A. Fein expects that the ...
SpringWorks Therapeutics’ (SWTX) “Buy” Rating Reaffirmed at HC Wainwright
HC Wainwright reiterated their buy rating on shares of SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) in a report ...
Cleanspark Unusual Options Activity
Looking at options history for Cleanspark CLSK we detected 29 trades. If we consider the specifics of each trade, it is accurate to state that 37% of the investors opened trades with bullish ...
H.C. Wainwright says SEC plan to dismiss suit lifts ‘major overhang’ on Coinbase
H.C. Wainwright analyst Mike Colonnese notes that Coinbase (COIN) announced that the Securities and Exchange Commission has agreed to dismiss ...
2RDW : Spotlight on Redwire: Analyzing the Surge in Options Activity
Delving into the details, we found 70% of traders were bullish, while 30% showed bearish tendencies. Out of all the trades we ...
Basilea projects CHF220M in 2025 revenue with key pipeline advancements and U.S. launch of Zevtera
Discover key insights from Basilea Pharmaceutica AG's Q4 2024 earnings call. Learn about robust revenue growth, FDA approvals, and pipeline advancements.
Axsome Therapeutics targets multiple NDA submissions and pipeline advancements through 2025
Axsome Therapeutics reports 66% Q4 revenue growth, blockbuster potential for Auvelity, and robust pipeline progress with 3 NDA filings and key ...
SoundHound AI, Inc. (SOUN): Among the Best Robinhood Stocks to Buy Under $20
We recently published a list of 12 Best Robinhood Stocks to Buy Under $20. In this article, we are going to take a look at ...